190 related articles for article (PubMed ID: 27219467)
1. Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants.
Khan SA; Desclozeaux M; Waugh C; Hanger J; Loader J; Gerdts V; Potter A; Polkinghorne A; Beagley K; Timms P
PLoS One; 2016; 11(5):e0156094. PubMed ID: 27219467
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine.
Khan SA; Polkinghorne A; Waugh C; Hanger J; Loader J; Beagley K; Timms P
Vaccine; 2016 Feb; 34(6):775-82. PubMed ID: 26747718
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses.
Khan SA; Waugh C; Rawlinson G; Brumm J; Nilsson K; Gerdts V; Potter A; Polkinghorne A; Beagley K; Timms P
Vaccine; 2014 Oct; 32(44):5781-6. PubMed ID: 25196393
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein.
Nyari S; Khan SA; Rawlinson G; Waugh CA; Potter A; Gerdts V; Timms P
PLoS One; 2018; 13(6):e0200112. PubMed ID: 29953523
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus).
Nyari S; Booth R; Quigley BL; Waugh CA; Timms P
PLoS One; 2019; 14(1):e0210245. PubMed ID: 30615687
[TBL] [Abstract][Full Text] [Related]
6. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P
PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology.
Kollipara A; George C; Hanger J; Loader J; Polkinghorne A; Beagley K; Timms P
Vaccine; 2012 Feb; 30(10):1875-85. PubMed ID: 22230583
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infection.
Kollipara A; Polkinghorne A; Beagley KW; Timms P
PLoS One; 2013; 8(9):e74808. PubMed ID: 24086379
[TBL] [Abstract][Full Text] [Related]
9. A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants.
Carey AJ; Timms P; Rawlinson G; Brumm J; Nilsson K; Harris JM; Beagley KW
Am J Reprod Immunol; 2010 Feb; 63(2):161-72. PubMed ID: 20064144
[TBL] [Abstract][Full Text] [Related]
10. Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus).
Kollipara A; Wan C; Rawlinson G; Brumm J; Nilsson K; Polkinghorne A; Beagley K; Timms P
Vaccine; 2013 Feb; 31(8):1217-23. PubMed ID: 23306372
[TBL] [Abstract][Full Text] [Related]
11. A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus).
Waugh C; Khan SA; Carver S; Hanger J; Loader J; Polkinghorne A; Beagley K; Timms P
PLoS One; 2016; 11(1):e0146934. PubMed ID: 26756624
[TBL] [Abstract][Full Text] [Related]
12. Genetic diversity of Chlamydia pecorum strains in wild koala locations across Australia and the implications for a recombinant C. pecorum major outer membrane protein based vaccine.
Kollipara A; Polkinghorne A; Wan C; Kanyoka P; Hanger J; Loader J; Callaghan J; Bell A; Ellis W; Fitzgibbon S; Melzer A; Beagley K; Timms P
Vet Microbiol; 2013 Dec; 167(3-4):513-22. PubMed ID: 24012135
[TBL] [Abstract][Full Text] [Related]
13. A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection.
Li Y; Zheng K; Tan Y; Wen Y; Wang C; Chen Q; Yu J; Xu M; Tan M; Wu Y
Appl Microbiol Biotechnol; 2019 Jan; 103(2):941-952. PubMed ID: 30467705
[TBL] [Abstract][Full Text] [Related]
14. Comparison of subcutaneous versus intranasal immunization of male koalas (Phascolarctos cinereus) for induction of mucosal and systemic immunity against Chlamydia pecorum.
Waugh CA; Timms P; Andrew D; Rawlinson G; Brumm J; Nilsson K; Beagley KW
Vaccine; 2015 Feb; 33(7):855-60. PubMed ID: 25562793
[TBL] [Abstract][Full Text] [Related]
15. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
[TBL] [Abstract][Full Text] [Related]
16. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
17. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a
Sahu R; Dixit S; Verma R; Duncan SA; Smith L; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2021; 12():660932. PubMed ID: 33936096
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
20. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
